William Blair Investment Management
VRTX icon

William Blair Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

William Blair Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7M Sell
39,547
-188
-0.5% -$87.7K 0.06% 263
2025
Q4 		$18M Buy
39,735
+39,139
+6,567% +$16.9M 0.05% 288
2025
Q3 		$233K Sell
596
-22,012
-97% -$9.2M ﹤0.01% 405
2025
Q2 		$10.1M Sell
22,608
-56,724
-72% -$26.1M 0.03% 327
2025
Q1 		$38.5M Buy
79,332
+1,800
+2% +$839K 0.11% 168
2024
Q4 		$31.2M Buy
77,532
+983
+1% +$456K 0.08% 245
2024
Q3 		$35.6M Buy
+76,549
New +$36.8M 0.09% 194

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

William Blair Investment Management's VRTX Position: Q1 2026 in Review

William Blair Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 0.47% in Q1 2026, selling an estimated $87.7K and leaving 39,547 shares worth $17.7M. The position accounts for 0.06% of the portfolio, ranked #263.

William Blair Investment Management first reported a position in VRTX in Q3 2024 and has held it in 7 quarters since. The position peaked at $38.5M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • William Blair Investment Management held 39,547 shares of Vertex Pharmaceuticals worth $17.7M as of Q1 2026.
  • William Blair Investment Management sold 188 Vertex Pharmaceuticals shares in Q1 2026, an estimated $87.7K.
  • Vertex Pharmaceuticals made up 0.06% of William Blair Investment Management's portfolio in Q1 2026, its #263 holding.
  • William Blair Investment Management first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • William Blair Investment Management's Vertex Pharmaceuticals position peaked at $38.5M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on William Blair Investment Management's 13F filing for Q1 2026, filed 8 May 2026.